Staged Pancreatic β Cell Production for High-Quality Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for differentiating pluripotent stem cells into pancreatic β cells are inefficient and result in low-quality cells for therapeutic applications.
Innovation Solution
A method involving sequential culture steps with specific growth factors and inhibitors, including protein kinase C activators, retinoic acid, Notch and ROCK signaling inhibitors, and insulin receptor activators, to differentiate primitive gut tube cells into pancreatic β cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional differentiation methods are used to generate pancreatic β cells from pluripotent stem cells, then the process can be completed, but the differentiation efficiency is low and the quality of generated cells is insufficient for therapeutic applications
Solution Approach 1:
The differentiation process is divided into six distinct stages with specific culture conditions for each: Stage 1 (endodermal cells), Stage 2 (primitive gut tube cells), Stage 3 (posterior foregut cells), Stage 4 (pancreatic progenitor cells), Stage 5 (pancreatic endocrine precursor cells), and Stage 6 (pancreatic β cells). This segmentation allows optimization of each stage independently to improve overall efficiency and cell quality.
Solution Approach 2:
The invention employs systematic changes in culture parameters including specific growth factors (EGF, FGF7, FGF10, IGF-1, insulin), hormones (dexamethasone, retinoic acid), and signaling inhibitors (GSK3β inhibitor, Notch inhibitor, ROCK inhibitor) at different stages to guide differentiation efficiently while maintaining high cell quality.
2Productivity
If existing differentiation protocols are applied, then pancreatic β cells can be produced, but the process is inefficient and time-consuming
Solution Approach 1:
The invention performs preliminary actions by establishing optimal culture conditions for each differentiation stage in advance, including pre-determination of growth factor concentrations and timing of inhibitor additions, which streamlines the overall process and reduces unnecessary time delays.
Solution Approach 2:
The differentiation protocol maintains continuous useful action through overlapping culture periods where cells progress through stages without interruption, with each stage's culture conditions optimized to ensure seamless transition to the next stage, thereby reducing total production time while maintaining efficiency.
Data Source
AI summary
A problem addressed by the present invention is to provide a method for producing pancreatic β cells from endothermal cells that have been induced to differentiate from pluripotent stem cells, wherein the method allows the production of pancreatic β cells of high quality, and to provide pancreatic progenitor (PP) cells, pancreatic endocrine precursor (EP) cells, and pancreatic β cells produced by the above-mentioned method. The present invention provides a method for producing pancreatic β cells that includes culturing primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a protein kinase C (PKC) activator, thereby producing posterior foregut (PFG) cells; next culturing the cells in the presence of retinoic acid or an analog thereof, thereby producing pancreatic progenitor (PP) cells; next culturing the cells in the presence of a Notch signaling inhibitor and a ROCK signaling inhibitor, thereby producing pancreatic endocrine precursor (EP) cells; and next culturing the cells in the presence of an insulin receptor signaling activator, transferrin, and selenous acid, thereby producing pancreatic β cells.